Health News

Rx Combo May Trigger Serious Reactions
Some things just don't mix — and that applies to medications. One antibiotic combined with statins may be dangerous. Fortunately, other types of antibiotics may be safer when mixed with statins.
Cutting Out Sugary Drinks for Better Health
Cutting down on sugary sodas and energy drinks may not only help you stick to your calorie goal; it also might help reduce your disease risk as well.
Generic Statins as Good as Brand Name
Statins  are medications used for the treatment of high cholesterol. They come in many branded and generic forms. Does it matter which one a physician prescribes?
Diabetes-Lipitor Link Isn't Found in Everyone
Drug treatment can prevent heart problems for those at risk. However, certain drugs may lead to other serious health issues, including diabetes.
It's the Pharmacist Calling
When life is busy, a trip to the pharmacy for a new prescription can be a hassle. A recent study found that a reminder might be helpful.
Ranbaxy Issues Voluntary Nationwide Recall of Atorvastatin Calcium
On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of atorvastatin calcium tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail level.
(UPDATE 12/15) FDA Announces New Safety Recommendations For High-Dose Simvastatin
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy , particularly during the first 12 months of use.
Vegans Vexed?
Vegans -- individuals who don't eat animal products, including dairy -- may be prone to atherosclerosis or hardening of the arteries, according to a new study.
Disheartening Figures
Heart disease costs are predicted to triple in the next 20 years in the U.S., according to predictions from the American Heart Association (AHA).
Costs of Cardiovascular Disease Enough to Make Your Heart Race
Costs associated with treating heart disease and heart conditions increased more than 200 percent in Canada from 1996 to 2006, and are expected to triple in the U.S. by 2030.